Question 1

What is the catalog number for CD160, Recombinant, Human, His-Tag discontinued?

Accepted Answer

The catalog number for CD160, Recombinant, Human, His-Tag discontinued is 590790.

Question 2

What sizes are available for CD160, Recombinant, Human, His-Tag discontinued?

Accepted Answer

CD160, Recombinant, Human, His-Tag discontinued is available in the following size(s): 20 µg, 100 µg.

Question 3

How many pack sizes does CD160, Recombinant, Human, His-Tag discontinued come in?

Accepted Answer

CD160, Recombinant, Human, His-Tag discontinued is available in 2 different pack sizes.

Question 4

Is CD160, Recombinant, Human, His-Tag discontinued in stock?

Accepted Answer

CD160, Recombinant, Human, His-Tag discontinued is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Question 6

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Question 7

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

CD160, Recombinant, Human, His-Tag discontinued

Product Specifications

Available Sizes

Frequently Asked Questions

Explore Other Products

1- (5- (Tert-Butyl) Pyrazin-2-Yl) Ethan-1-One

1- (5- (Tert-Butyl) Pyrazin-2-Yl) Ethan-1-One

1- (5- (Tert-Butyl) Pyrazin-2-Yl) Ethan-1-One

1- (5- (Tert-Butyl) Pyrazin-2-Yl) Ethan-1-One

Tmem209 Rat shRNA Plasmid (Locus ID 312200)

Rufy1 sgRNA CRISPR Lentivector (Mouse) (Target 3)